In recent years, the new immune-based therapy CAR T has dramatically improved outcomes for patients with certain blood cancers that involve B cells, like leukemia and lymphoma. Dr. Georg Schett, a ...
San Francisco, CA- June 20. The Lupus Research Alliance (LRA) announced the recipients of the 2024 Lupus Insight Prize to Marko Radic, Ph.D., The University of Tennessee Health Science Center, and ...
Appointments come as CREATE advances CRT-402, its lead in vivo CD19 CAR-T program, to clinical development for B cell-driven autoimmune disease CAMBRIDGE, Mass., May 14, 2026 /PRNewswire/ -- CREATE ...
Georg Schett has upended our understanding of autoimmune diseases, and what treating them can accomplish. Using CAR-T therapies, Schett and his colleagues in Erlangen, Germany, have managed to put ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results